Adamax
Next-Generation Semax Derivative | Nootropic Neuropeptide
Overview
Synthetic nootropic peptide with N-terminal acetylation and C-terminal adamantane modification for superior stability and blood-brain barrier penetration, researched for cognitive enhancement, neuroprotection, and neuroplasticity.
Key benefits
- Enhanced cognitive function and mental clarity
- Improved focus and complex task handling
- Neuroprotection against oxidative stress
- Neuroplasticity support through BDNF upregulation
- Potential mood enhancement
- Stress resilience through HPA axis modulation
Mechanism of action
Crosses BBB via enhanced lipophilicity from adamantane; upregulates BDNF and TrkB receptor sensitivity; modulates dopamine, norepinephrine, and serotonin; stabilizes microtubules via ADNP-derived mechanisms; provides antioxidant and anti-inflammatory neuroprotection.
Molecular data
- Type
- Modified heptapeptide derivative
- Half-life
- 8-10 hours
Sequence
Ac-Met-Glu-His-Phe-Pro-Gly-Pro-AGly-NH2
Indications
What the research community uses this compound for, with self-reported effectiveness.
Cognitive
Cognitive Enhancement
Most effectivePreliminary research suggests improvements in focus, mental clarity, memory consolidation, and complex task handling.
Neuroplasticity Support
Most effectiveBDNF upregulation and TrkB enhancement promote new neural connections and synaptic plasticity for long-term improvements.
Learning and Memory
Most effectiveMay enhance memory formation, information retention, and learning efficiency through hippocampal BDNF-TrkB pathway activation.
Neuroprotective
Stroke Recovery
EffectivePreliminary observations indicate improved neurological outcomes through oxidative stress reduction and neuronal repair.
Oxidative Stress Protection
EffectiveDemonstrates antioxidant properties protecting against oxidative damage and inflammation-induced neuronal injury.
Neuronal Maintenance
EffectiveSupports neuronal survival and growth through BDNF enhancement and microtubule stabilization.
Mood
Mood Enhancement
ModerateInfluences serotonin and dopamine to elevate mood and reduce depressive symptoms through neurotransmitter modulation.
Anxiety Reduction
ModerateAnecdotal reports indicate reduced overwhelm and anxiety through balanced neurotransmitter activity.
Stress Resilience
ModerateHPA axis modulation may improve stress response and emotional well-being.
Dosing protocols
Common protocols by delivery method. Adjust the curve below to model accumulation in your own cycle.
Injectable
Enhanced cognitive function and neuroprotection through direct systemic delivery with superior bioavailability.
| Protocol | Dose | Frequency | Route / duration |
|---|---|---|---|
| Cognitive Enhancement | 200-300mcg | 1x daily | SubQ |
| Neuroprotection | 300mcg | 1-2x daily | SubQ |
| Mood Support | 200mcg | 1x daily (morning) | SubQ |
| Initial Trial | 100-200mcg | 1x daily | SubQ |
Preparation
You will need
- Bacteriostatic water (BAC)
- Insulin syringes (0.5-1mL)
- Alcohol swabs
- Peptide vial
- Sterile work surface
Steps
- Clean work area and hands thoroughly with alcohol
- Calculate required BAC water volume using calculator
- Draw calculated BAC water into syringe
- Inject slowly down vial side (not directly onto powder)
- Gently swirl until completely dissolved (never shake vigorously)
- Store reconstituted solution in refrigerator at 2-8°C
- Use within 14-30 days for optimal potency
Work out the water volume and syringe units in the reconstitution calculator →
Oral
Convenient non-injectable administration with potentially smoother cognitive effects; lower bioavailability than injectable route.
| Protocol | Dose | Frequency | Route / duration |
|---|---|---|---|
| Cognitive Enhancement | 100-200mg | 1x daily (morning) | Oral/Sublingual |
| Sustained Focus | 100-200mg | 2x daily (morning, early afternoon) | Oral/Sublingual |
| Mood Support | 100mg | 1x daily (morning) | Oral/Sublingual |
| Initial Assessment | 100mg | 1x daily | Oral/Sublingual |
Interactions
Pairwise interactions with other compounds you might be cycling — the same data behind the cycle builder's safety check.
Noopept
MonitorBoth enhance cognition through different mechanisms but share BDNF upregulation; start lower doses and monitor for overstimulation.
Semax
CompatibleAdamax is an enhanced derivative with improved stability and bioavailability.
P21
SynergisticAdamax incorporates adamantyl portion from P21; may complement cognitive benefits.
BPC-157
CompatibleDifferent mechanisms—Adamax targets neurological function; BPC-157 focuses on tissue repair.
Timeline
Typical week-by-week effects reported in clinical and observational data.
- Hours 1-4
Potential acute cognitive enhancement and improved focus
- Week 1-2
Enhanced mental clarity, reduced anxiety, improved mood
- Week 2-4
Neuroplasticity benefits, sustained cognitive improvements
- Week 4+
Maximum neuroprotective and structural brain benefits
Safety
Reported adverse effects, contraindications, and what to monitor on cycle.
Common side effects
- Headaches (particularly at higher doses)
- Insomnia or sleep disruption
- Anxiety or overstimulation
- Cardiovascular effects (elevated blood pressure, palpitations)
Stop signs — stop and seek advice
- Persistent or severe headaches
- Chest pain, heart palpitations, or significant blood pressure increases
- Severe anxiety, insomnia, or mood disturbances
- Unusual neurological symptoms or mental status changes
- Persistent injection site reactions or infection signs
- Gastrointestinal distress (nausea, vomiting, diarrhea)
Contraindications
- Pregnancy and breastfeeding
- Cardiovascular conditions (without medical supervision)
- Severe anxiety disorders
- Uncontrolled hypertension
Monitoring
- Assess individual response at lower initial doses
- Monitor cardiovascular parameters
- Track tolerance development over cycling periods
- Observe for mood or sleep changes
- Use sterile injection technique to prevent infection
Quality checks
What a legitimate product looks like, what should give pause, and what should make you stop.
Good signs
- White, fluffy powder indicating proper freeze-drying
- Clear solution after reconstitution with no particles or cloudiness
- Proper labeling with peptide name, batch number, manufacturing date
Warning signs
- Slight compaction from shipping acceptable if powder dissolves completely
Stop signs — don't use
- Discoloration or yellowing indicates oxidation or degradation
- Persistent cloudiness or particles indicate degradation or contamination
Recent research
Newer papers and trial readouts on file for this compound, with source and date.
2025 · International Journal of Molecular Sciences
The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease
Semax and its derivative improved cognitive functions in Alzheimer's transgenic mice with 2.8-fold reduction in amyloid plaques, supporting the therapeutic potential of Semax-family derivatives including Adamax.
2025 · Bioinorganic Chemistry and Applications
Semax, a Copper Chelator Peptide, Decreases Cu(II)-Catalyzed ROS Production and Cytotoxicity of Abeta
Semax extracts Cu(II) from amyloid-beta complexes and reduces ROS production, demonstrating neuroprotective copper-chelation properties shared by the Semax peptide family.
2025 · British Journal of Pharmacology
Semax Peptide Targets Mu Opioid Receptor Gene Oprm1 for Functional Recovery After Spinal Cord Injury
Semax improved spinal cord injury functional recovery via mu-opioid receptor targeting and USP18 deubiquitination pathway, expanding understanding of Semax-family neuroprotective mechanisms.
References
Primary literature and clinical-trial data informing this entry.
A Nootropic Adrenocorticotropin Analog 4-10 Semax: 15 Years Experience in Its Design and Study (Parent Compound)
Ashmarin IP, Nezavibatko VN, Levitskaya NG, et al. · Zhurnal Vysshei Nervnoi Deiatelnosti imeni I.P. Pavlova · 1997
Foundational Semax review: intranasal doses stimulate operative memory and attention for 20-24 hours. Adamax builds on the Semax core sequence with adamantane modification for enhanced stability and BBB penetration.
Semax, an Analog of ACTH(4-10), Regulates BDNF and trkB Expression in the Rat Hippocampus (Parent Compound)
Dolotov OV, Karpenko EA, Inozemtseva LS, et al. · Brain Research · 2006
Single application at 50 mcg/kg produced 1.4-fold increase in BDNF protein and 1.6-fold increase in trkB tyrosine phosphorylation in rat hippocampus, supporting Adamax's BDNF-TrkB mechanism.
The Efficacy of Semax in the Treatment of Patients at Different Stages of Ischemic Stroke (Parent Compound)
Gusev EI, Barskov IV, et al. · Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova · 2018
110 ischemic stroke patients; Semax (6000 mcg/day intranasal) increased BDNF plasma levels and accelerated functional recovery, providing the clinical basis for Adamax neuroprotective applications.
The Peptide Semax Affects the Expression of Genes Related to the Immune and Vascular Systems in Rat Brain Focal Ischemia (Parent Compound)
Dergunova LV, Limborska SA, et al. · BMC Genomics · 2014
Genome-wide analysis: Semax modulated 24 vascular genes at 3h and enhanced immune-response gene expression at 24h post-ischemia, demonstrating multi-pathway neuroprotection.
Last updated . How this page was sourced is described in the methodology.